Notably, the average expression level of ANT3 in all hematological malignancies included in the database, including myeloid leukemia, lymphoma, and myeloma cell lines, ranked at the forefront of all tissue-derived tumors. The gene discussed is SLC25A6; the disease is myeloid leukemia.